LAMP1 and Alzheimer disease: In a report studying individuals with mild AD, there was no change in NK cell activation capacity when comparing the expression of CD107a, a marker for granular release, and levels of granzyme B and IFN-γ (Le Page et al., 2015); however, it is not known how these cells may be altered in individuals with severe AD.